PRESS RELEASES

TJP Labs Completes Multi-Million Dollar Investment Round to Continue Global Expansion into Modern Oral Nicotine Manufacturing

PICKERING, Ontario, Aug. 31, 2021 (GLOBE NEWSWIRE) — TJP Labs Inc. (“TJP Labs”), one of North America’s leading full-service contract manufacturers of next-generation nicotine products, announced its launch of Canada’s first modern oral nicotine contract manufacturing facility for buccal nicotine pouches. TJP Labs will provide international brands (and when authorized for sale in Canada, domestic […]

PRESS RELEASES

TRIO Enrols First Patient in Global Phase 3 Giredestrant Early Breast Cancer Trial

EDMONTON, Alberta, Aug. 31, 2021 (GLOBE NEWSWIRE) — Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of first patient in the LidERA Breast Cancer (TRIO045) trial, a Phase 3 randomized, multi-center, open-label global clinical trial of adjuvant endocrine therapy, giredestrant (GDC-9545) sponsored by F. Hoffmann-LaRoche. Giredestrant is an oral […]

PRESS RELEASES

Peplink brings SpeedFusion’s Unbreakable Edge to Ericsson’s Industry 4.0 Partner Program

VILNIUS, Lithuania, Aug. 31, 2021 (GLOBE NEWSWIRE) — Peplink is partnering with Ericsson to deliver SpeedFusion technology to Industry 4.0 networks – allowing for greater scalability and seamless switching between different edge technologies so industrial networks can grow and remain productive in any scenario. Peplink’s vast portfolio of LTE and 5G routers and its SpeedFusion […]

PRESS RELEASES

Global Dairy Platform Announces New Board Chair

Hein Schumacher ROSEMONT, Ill., Aug. 31, 2021 (GLOBE NEWSWIRE) — Global Dairy Platform (GDP), a not-for-profit industry association representing the international dairy sector, today announced the appointment of Hein Schumacher, Chief Executive Officer of Royal FrieslandCampina, as Chair of GDP’s Board of Directors. Schumacher succeeds Rick Smith, President and Chief Executive Officer of Dairy Farmers […]

PRESS RELEASES

Junshi Biosciences Announces 2021 Interim Financial Results and Provides Corporate Updates

SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the six months ended June 30, 2021 and provided corporate updates. First Half 2021 Financial Highlights Total revenue reached RMB 2,114 […]